Clinical Trial Update: Proteomics and Genomics Combined With CT to Predict CVD

View source ↗

Summary

A clinical trial from AMC-UvA is investigating using proteomics and genomics in combination with CT imaging to predict coronary artery disease progression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Coronary Artery Disease Progression | Status: ACTIVE_NOT_RECRUITING